Glucotrack, Inc.: files pro forma financials for Lokahi merger

What happened Glucotrack, Inc. filed an 8-K on Oct 13, 2026 reporting unaudited pro forma combined financial information for the merger with Lokahi Therapeutics Inc. The unaudited pro forma combined balance sheet is presented as of Jun 30, 2026 and reflects the effects of the merger and a 1-for-15 reverse stock split that became effective on Aug 28, 2026. The unaudited pro forma combined statements of operations cover the year ended Dec 31, 2025 and the six months ended Jun 30, 2026 and assume the merger closed on Jan 1 of the respective year.

Key details

• Unaudited pro forma combined balance sheet date: Jun 30, 2026.
• Pro forma statements of operations for the year ended Dec 31, 2025 and six months ended Jun 30, 2026 assume the merger closed on Jan 1 of the respective year.
• The pro forma financials give effect to a 1-for-15 reverse stock split effective Aug 28, 2026.
• The unaudited pro forma condensed combined financial information is included as Exhibit 99.1 to the filing.

Why it may matter This 8-K reports Item 9.01 pro forma financial information, which provides unaudited combined financial statements that reflect the accounting effects of the merger with Lokahi Therapeutics Inc. and the 1-for-15 reverse stock split. The filing does not show why the insider traded or why the company acted.